Table 1.
Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of thiazole compounds 1 and 2, teicoplanin, and vancomycin against methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA), and vancomycin-resistant Staphylococcus aureus (VRSA) strains.
MIC and MBC (µgml−1) of thiazole compounds, teicoplanin, and vancomycin against S. aureus |
|||||||||
---|---|---|---|---|---|---|---|---|---|
Strain | 1 | 2 | Teicoplanin | Vancomycin | |||||
MIC | MBC | MIC | MBC | MIC | MBC | MIC | MBC | ||
MRSA | NRS107 | 1.38 | 2.77 | 1.40 | 1.40 | 0.94 | 0.94 | 0.74 | 1.49 |
NRS119 | 1.38 | 1.38 | 1.40 | 1.40 | 0.94 | 0.94 | 0.74 | 1.49 | |
NRS123 (USA400) | 1.38 | 11.07 | 1.40 | 5.58 | 0.94 | 15.04 | 0.37 | 0.37 | |
NRS194 | 1.38 | 5.54 | 1.40 | 11.17 | 0.94 | 15.04 | 0.74 | 0.74 | |
NRS384 (USA300) | 1.38 | 1.38 | 1.40 | 2.80 | 0.94 | 15.04 | 0.74 | 0.74 | |
NRS385 (USA500) | 1.38 | 1.38 | 1.40 | 1.40 | 0.94 | 3.76 | 0.74 | 0.74 | |
ATCC 43300 | 1.38 | 2.77 | 1.40 | 2.80 | 0.94 | 3.76 | 0.74 | 0.74 | |
VISA | NRS1 | 1.38 | 1.38 | 0.70 | 1.40 | 3.76 | 7.52 | 2.97 | 2.97 |
NRS19 | 1.38 | 1.38 | 1.40 | 1.40 | 0.94 | 0.94 | 2.97 | 2.97 | |
NRS37 | 1.38 | 1.38 | 0.70 | 1.40 | 7.52 | 7.52 | 2.97 | 2.97 | |
VRSA | VRS1 | 2.77 | 2.77 | 1.40 | 1.40 | 120.30 | 240.60 | 760.68 | 760.68 |
VRS4 | 2.77 | 2.77 | 0.70 | 2.80 | 60.15 | 60.15 | 760.68 | 760.68 | |
VRS5 | 2.77 | 5.54 | 1.40 | 5.58 | 60.15 | 60.15 | 760.68 | 760.68 | |
S. epidermidis | ATCC 35984 | 2.77 | N.D. | 0.70 | N.D. | N.D. | N.D. | 0.74 | N.D. |
Abbreviation: N.D. = Not Determined